Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata is an incurable autoimmune condition causing hair loss, with research aiming for better treatments.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

The dense fine speckled pattern in ANA tests is common in autoimmune diseases, challenging previous beliefs that it was unrelated.

People with alopecia areata often have higher rates of allergies and autoimmune diseases.

Targeted cytokine treatments may help with alopecia areata, but more research is needed.

Thyroid diseases may contribute to autoimmune skin diseases, and more research is needed on their relationship.

AIRE protein, defective in APECED patients, is found in skin and hair cells and interacts with cytokeratin 17.

People with Lichen Planopilaris are more likely to have autoimmune diseases, especially Systemic Lupus Erythematosus, and less likely to have diabetes and some other common conditions.

Volatile organic compounds can cause inflammation and increase the risk of autoimmune diseases.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

Alopecia areata patients, especially women with nail issues or atopic diseases, are at higher risk for other autoimmune diseases.

Atopic dermatitis increases the risk of some autoimmune diseases.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Breast implants are linked to autoimmune symptoms, with over half of patients feeling better after removal, but the exact cause is unclear and may involve bacterial biofilm.

Frontal fibrosing alopecia may be linked to genital Lichen sclerosus through an autoimmune process.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.

IVIg treatment improved symptoms but caused permanent dark hair loss.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

Alopecia Areata is an autoimmune hair loss condition, with various treatments showing mixed effectiveness and no guaranteed cure.

DNA methylation is essential for skin and hair follicle development, and could be a target for treating skin diseases.

The conclusion suggests that treatments targeting root causes of chronic diseases may be developed by focusing on gene expression and lifestyle factors.

Nanostructured lipid carriers effectively deliver tofacitinib to hair follicles, reversing hair loss in alopecia areata.

Satoyoshi syndrome is likely an autoimmune disease that mainly affects young women and improves with immune-related treatments.

The PTH-CBD injection improved hair regrowth better than the daily ruxolitinib pill in mice.

Biomedical engineers are crucial for developing better treatments for chronic and autoimmune diseases.

The conclusion is that women are heavily affected by autoimmune skin diseases, face significant challenges, and need better research, treatments, and healthcare policies.

Transplanted hair follicles can resist hair loss from an autoimmune condition better than natural hair.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Targeting the skin's endocannabinoid system could help treat skin disorders.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.